# Baird Inc

> Baird Inc is a VC fund in Sarasota backing Life Science and Neuroscience. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sarasota, United States
- Total investments: 1
- Last investment: Jul 2021
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bairdinc/
- Website: http://www.bairdinc.com/

Baird Inc is a VC fund in Sarasota focused on Life Science and Neuroscience. Baird Inc specializes in financing solutions to serve the needs of small-cap and mid-market businesses.

## Contacts

5 contacts available for Baird Inc. Shizune tracks 1 team members at Baird Inc. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/baird-inc?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Neuroscience | 1 | 100% |
| Biotechnology | 1 | 100% |
| Mental Health | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Eric Baird | Founder & CEO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Psilera | Psilera develops therapies aimed at neurological and psychiatric disorders by leveraging neuroplastogens, compounds that promote brain plasticity without hallucinogenic effects. The company builds a proprietary library of serotonergic compounds and applies computational tools to design molecules for conditions such as alcohol use disorder andfrontotemporal dementia. Its research pipeline emphasizes non-hallucinogenic derivatives of psychedelic compounds to provide safe and scalable treatment options. Psilera integrates medicinal chemistry, neuroscience, and pharmacology to create small-molecule drugs that address unmet medical needs. Through this approach, the company seeks to expand treatment possibilities for patients facing hard-to-treat neurological conditions. | $2.5M | Seed | Jul 01, 2021 |  |

1 of 1 investments shown.

## Co-investors
- [Iter Investments](https://shizune.co/investors/profile/iter-investments) — VC Fund, 1 deal together
- [JLS Fund](https://shizune.co/investors/profile/jls-fund) — VC Fund, 1 deal together
- [Receptor](https://shizune.co/investors/profile/receptor-cd70) — VC Fund, 1 deal together
- [What If Ventures](https://shizune.co/investors/profile/what-if-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Baird Inc invest in?

Baird Inc invests primarily in Life Science, Neuroscience and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Baird Inc?

Public channels for Baird Inc include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Baird Inc?

The team at Baird Inc includes Eric Baird (Founder & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co